Add-on Protective Effect of Pentoxifylline in Advanced Chronic Kidney Disease Treated with Renin-Angiotensin-Aldosterone System Blockade - A Nationwide Database Analysis

A combination therapy of pentoxifylline with an angiotensin converting enzyme inhibitor (ACEI) or an angiotensin II receptor blocker (ARB) decreased proteinuria or glomerular filtration rate decline in early chronic kidney disease (CKD). Whether adding pentoxifylline to ACEI/ARB provides additional...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Ko-Lin, Hung, Szu-Chun, Liu, Jia-Sin, Chang, Yu-Kang, Hsu, Chih-Cheng, Tarng, Der-Cherng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661470/
https://www.ncbi.nlm.nih.gov/pubmed/26612282
http://dx.doi.org/10.1038/srep17150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661470/
https://www.ncbi.nlm.nih.gov/pubmed/26612282
http://dx.doi.org/10.1038/srep17150

Ejemplares similares